A case of denosumab-induced hypocalcaemia in a patient with non-metastatic prostate cancer and renal impairment

Denosumab is an emerging new treatment for osteoporosis in postmenopausal women and men with non-metastatic prostate cancer. It is largely used by specialists as an alternative treatment in patients with contraindications to traditional, more commonly used drugs such as bisphosphonates. One importan...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of the Royal College of Physicians of Edinburgh 2015, Vol.45 (2), p.133-135
Hauptverfasser:	Blackley, S, Anderson, K, Berg, J
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged, 80 and over Bone Density Conservation Agents - adverse effects Calcium - therapeutic use Denosumab - adverse effects Humans Hypocalcemia - chemically induced Male Prostatic Neoplasms - complications Renal Insufficiency - complications Vitamin D - analogs & derivatives Vitamin D - blood Vitamin D - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!